Transfusion Practice & Adverse Reactions · 수혈 실무와 수혈 부작용
A hospital transfusion service that performed compatibility testing confirms that a patient's death was caused by a hemolytic transfusion reaction. What are its FDA reporting obligations?
1Include it only in the facility's annual summary of transfusion adverse events
2Notify CBER as soon as possible and submit a written report within 7 days✓ 정답
3Report only if the blood supplier requests it
4Submit a biological product deviation report to FDA within 45 calendar days
해설
Under 21 CFR 606.170(b), the facility that performed compatibility testing must notify FDA CBER as soon as possible after a transfusion fatality is confirmed and send a written investigation report within 7 days. The 45-day timeline belongs to biological product deviation reporting, not fatality reporting.